SCHEMBL21515083

SCHEMBL21515083

CCOC(=O)CCCNC(=O)c1ncc(NC(N)=O)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MAPT P10636 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ CYP2D6 P10635 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA3 P07451 1/20 0.38
▸ CA4 P22748 1/20 0.38
▸ CA6 P23280 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21515018 0.79 MAPT (0.51) CYP3A4CYP2C19CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL21515061 0.78 CYP3A4 (0.47) CYP3A4CYP2C19CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL21515092 0.73 CYP1A2 (0.45) CYP3A4CYP2C19CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL25745901 0.71 SMN1; SMN2 (0.42) SMN1; SMN2KDM4EEPHX2
SCHEMBL21515131 0.71 L3MBTL1 (0.49) ALDH1A1KDM4EHPGDMAPT
SCHEMBL18236244 0.70 CYP1A2 (0.52) CYP3A4CYP2C19CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL23501744 0.69 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KDM4EHPGDMAPT
SCHEMBL28516903 0.69 L3MBTL1 (0.47) ALDH1A1KDM4EHPGDMAPT
SCHEMBL15400405 0.69 CYP3A4 (0.68) CYP3A4CYP2C19CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL17891818 0.69 CYP1A2 (0.57) CYP3A4CYP2C19CYP1A2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019201991-A1 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING (SE) 2019-10-24 — — WO disclosed
Send feedback